Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate;Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né

Revue Medicale Suisse

Volumn 1, Issue 36, 2005, Pages 2315-2326

  Meylan, Pascal ^a   Büchner, Stanislaw ^b   Erni, Petra ^c   Garweg, Justus ^d   Stefan, Gerber ^a   Hirsch, Hans H ^b   Kempf, Werner ^e   Kind, Christian ^f   Lauper, Urs ^g   Lautenschlager, Stefan ^h   Nadal, David ⁱ   Reusser, Pierre ^j   Wunderli, Werner ^k  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f Ostschweizer Kinderspital   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h Dermatologisches Ambulatorium   (Switzerland)

ⁱ UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^j Basel University School of Medicine   (Switzerland)

^k HUG   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; FAMCICLOVIR; VALACICLOVIR;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; MEDICAL SOCIETY; NEWBORN; PATIENT CARE; PROGNOSIS; REVIEW; SOCIAL PSYCHOLOGY; SWITZERLAND; TREATMENT INDICATION; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION; ADULT; ARTICLE; DISEASE TRANSMISSION; FEMALE; HERPES SIMPLEX; NEWBORN DISEASE; PRACTICE GUIDELINE; PREGNANCY;

ADULT; DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PRACTICE GUIDELINES; PREGNANCY; SWITZERLAND;

EID: 32944467934     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Patel R, Barton SE, Brown D, et al. European guideline for the management of genital herpes. Intern. J of STD & AIDS 2001;12(Suppl 3):34-9.
2. Workowski KA, Levine WC, Wasserheit JN. U.S. Centers for disease control and prevention guidelines for the treatment of sexually transmitted diseases: An opportunity to unify clinical and public health practice. Ann Intern Med 2002;137:255-62.
3. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999;341:1432-8.
4. Diamond C, Selke S, Ashley R, Benedetti J, Corey L. Clinical Course of Patients With Serologic Evidence of Recurrent Genital Herpes Presenting With Signs and Symptoms of First Episode Disease. Sex Transm Dis 1999;26:221-5.
5. Lowhagen GB, Tunback P, Andersson K, Bergstrom T, Johannisson G. First episodes of genital herpes in a Swedish STD population: A study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infec 2000;76:179-82.
6. Jolivet P, Meylan PRA. Herpès génital: L'é pidémie silencieuse? Médecine et Hygiène 2001;59:781-9.
7. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131:14-20.
8. Buenzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan P. Seroepidemiology of Herpes Simplex Virus type 1 and 2 in western and southern Switzerland in adults aged 25-74 in 1992-93: A population-based study. BMC Infectious Diseases 2004;4:10.
9. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
10. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
11. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-6.
12. Corey L, Wald A, Patel R, et al. Once-daily valaciclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.
13. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: Impact on surveillance and prevention. J Infect Dis 2000 Apr;181:1454-7.
14. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002;185:45-52.
15. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: Clinical manifestations, course, and complications. Ann Intern Med 1983;98:958-72.
16. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
17. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847-54.
18. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-9.
19. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
20. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having «asymptomatic» herpes simplex virus type 2 infection. Ann Intern Med 1989;110:882-7.
21. Lautenschlager S, Eichmann A. The heterogeneous clinical spectrum of genital herpes. Dermatology 2001;202:211-9.
22. Slomka MJ, Emery L, Munday PE, Moulsdale M, Brown DW. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 1998;55:177-83.
23. Coyle PV, Desai A, Wyatt D, McCaughey C, O'Neill HJ. A comparison of virus isolation, indirect immunofluorescence and nested multiplex polymerase chain reaction for the diagnosis of primary and recurrent herpes simplex type 1 and type 2 infections. J Virol Methods 1999;83:75-82.
24. Scoular A, Gillespie G, Carman WF. Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect. 2002;78:21-5.
25. Schmid DS, Brown DR, Nisenbaum R, et al. Limits in reliability of glycoprotein G-based type specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999;37:376-9.
26. Corey L, Nahmias AJ, Guinan ME, Benedetti JK, Critchlow CW, Holmes KK. A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med 1982;306:1313-9.
27. Bryson YJ, Dillon M, Lovett M, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med 1983;308:916-21.
28. Mindel A, Adler MW, Sutherland S, Fiddian AP. Intravenous acyclovir treatment for primary genital herpes. Lancet 1982;1:697-700.
29. Wald A. New therapies and prevention strategies for genital herpes. Clin Infect Dis 1999, 28(Suppl 1):S4-13.
30. Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis 1997;24:481-6.
31. Patel R. Progress in meeting today's demands in genital herpes: An overview of current management. J Infect Dis 2002;186(Suppl 1):S47-56.
32. Garcia A, Garcia S, Schanchez JA, Garcia I, Lanchares JL. Valaciclovir in the treatment of initial infection by genital herpes virus: Comparative study. Enferm Infecc Microbiol Clin 2001;19:15-8.
33. Corey L, Mindel A, Fife KH, Sutherland S, Benedetti J, Adler MW. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir. Sex Transm Dis 1985;12:215-8.
34. Mertz GJ, Critchlow CW, Benedetti J, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984;252:1147-51.
35. Peacock JE Jr, Kaplowitz LG, Sparling PF, et al. Intravenous acyclovir therapy of first episodes of genital herpes: A multicenter double-blind, placebo-controlled trial. Am J Med 1988;85:301-6.
36. Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: A randomised, double blind clinical trial. International Valaciclovir HSV Study Group. Genitourin Med 1997;73:1510-6.
37. Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Arch Intern Med 1996;156:1729-35.
38. Nilsen AE, Aasen T, Halsos AM, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982;2:571-3.
39. Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA 1984;25:2103-7.
40. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA 1996;276:44-9.
41. Wald A, Carrell D, Remington M, Kexel E, Zeh J, Corey L. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002;34:944-8.
42. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: A shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002;34:958-6.
43. Fife KH, Almekinder J, Madhura BP, Deeter RG. Episodic versus suppressive therapy for recurrent genital herpes. 41st ICAAC, Chicago, 2001.
44. Reitano M, Tyring S, Lang W, et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: A large-scale dose range-finding study. International Valaciclovir HSV Study Group. J Infect Dis 1998;178:603-10.
45. Goldberg LH, Kaufman R, Kurtz TO, Conant MA, Eron LJ, Batenhorst RL. Long-term suppression of recurrent genital herpes with acyclovir: A 5-year benchmark. Acyclovir Study Group. Arch Dermatol 1993;129:582-7.
46. Chosidow O, Drouault Y, Leconte-Veyriac F, et al. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: A parallel-groups, randomized, double-blind clinical trial. Br J Dermatol 2001;144:818-24.
47. Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: A randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA 1998;280:887-92.
48. Mertz GJ, Loveless MO, Levin MJ, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med 1997;157:343-9.
49. Patel R, Tyring S, Strand A, Price MJ, Grant DM. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect 1999;75:398-402.
50. Straus SE, Croen KD, Sawyer MH, Freifeld AG, Felser JM, Dale JK. Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment. JAMA 1988;260:2227-30.
51. Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infection: Long-term safety and sustained efficacy after 20 years' experience with acyclovir. J Infect Dis 2002;186 Suppl 1:S40-6.
52. Mindel A, Faherty A, Carney O, Patou G, Freris M, Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988;1:926-8.
53. Mertz GJ, Jones CC, Mills J, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA 1988;260:201-6.
54. Wade JC, Newton B, McLaren C, Flournoy N, Keeney RE, Meyers JD. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: A double-blind trial. Ann Intern Med 1982;96:265-9.
55. Shepp DH, Newton BA, Dandliker PS, Flournoy N, Meyers JD. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients. Ann Intern Med 1985;102:783-5.
56. Conant MA, Schacker TW, Murphy RL, Gold J, Crutchfield LT, Crooks RJ. Valaciclovir versus aciclovir for herpes simplex virus infections in HIV-infected individuals: Two randomized trials. Inf J STD AIDS 2002;13:12-21.
57. Romanowski B, Aoki FY, Martel AY, Lavender EA, Parsons JE, Saltzman RL. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group. AIDS 2000;14:1211-7.
58. Schacker T, Hu HL, Koelle DM, et al. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. Ann Intern Med 1998;128:21-8.
59. Corey L. Challenges in genital herpes simplex virus management. J Infect Dis 2002;186(Suppl 1):S29-33.
60. Green J, Kocsis A. Psychological factors in recurrent genital herpes. Genitourin Med 1997;73:253-8.
61. Meylan P. Neonataler Herpes, in: SPSU - Jahresbericht 2002. BAG Bulletin 2003;37:643.
62. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean section on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9.
63. Brown ZA, Benedetti J, Ashley R, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-52.
64. Hensleigh PA, Andrews WW, Brown Z, Greenspoon J, Yasukawa L, Prober CG. Genital herpes during pregnancy: Inability to distinguish primary and recurrent infections clinically. Obstet Gynecol 1997;89:891-5.
65. Briggs GG, Freeman RK, Yaffe SJ. A reference guide to fetal and neonatal risk: Drugs in pregnancy and lactation. Sixth ed, Lippincott Williams & Wilkins Philadelphia, PA-USA 2002.
66. Reiff-Eldridge RA, Heffner CR, Ephross SA, Tennis PS, White AD, Andres EB. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: A pharmaceutical company commitment. Am J Obstet Gynecol 2000;182:159-63.
67. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: A systematic review. Obstet Gynecol 2003;102:1396-402.
68. Watts DH, Brown ZA, Money D, et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol. 2003;188:836-43.
69. American Academy of Pediatrics. Herpes simplex. In: Pickering LK, ed. Red Book 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL. American Academy of Pediatrics 2003;344-53.
70. Major CA, Towers CV, Lewis DF, Garite TJ. Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol 2003;188:1551-5.
71. Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: Influence of timing of elective caesarean section. Br J Obstet Gynaecol. 1995;102:101-6.
72. Lecat M. Herpès cutanéo-muqueux chez l'immunocompé tent et grossesse. Ann Dermatol Venereol 2002;129:523-32.
73. National guideline for the management of genital herpes. Sex Transm Infect 1999;75:S24-8.
74. Huraux JM. Mesure préventive de l'herpès du nouveau-né: conférence de consensus de 1993 et nouvelles propositions. Ann Derm Venerol 2002;129:646-51.
75. Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA 1993;270:77-82.
76. ACOG practice bulletin. Management of herpes in pregnancy. Number 8 October 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000;68:165-73.
77. Brown ZA. Case study: Type-specific HSV serology and the correct diagnosis of first-episode genital herpes during pregnancy. Herpes 2002;9:24-6.
78. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
79. Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001;108:223-9.